Company Information & Drug Savings for Idorsia Ltd. Medications
Idorsia is a Swiss biopharmaceutical company developing innovative medicines for unmet medical needs. The company created QUVIVIQ (daridorexant), a dual orexin receptor antagonist for treating insomnia in adults. Idorsia’s research focuses on central nervous system disorders, rare diseases, and cardiovascular conditions where new therapeutic approaches are needed.
How to Contact Idorsia Ltd.
Phone
1-862-239-3070Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
